KT&G Corp (KT&G) manufactures and sells tobacco products, health foods, food and beverages, real estate and pharmaceutical products. It also operates real estate business.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

KT&G is actively engaged in the development of core and foundational technologies to enhance product competitiveness. The company focuses on creating new products for both domestic and export markets while improving existing offerings. Research efforts include the development of new analytical technologies for product quality assurance and safety verification. The company is continuously identifying new business areas for future growth, developing core technologies for next-generation product platforms, and strengthening its existing platform portfolio. The company aims to lead domestic market trends and develop products that meet global needs, establishing global, localized, and self-contained analysis systems. The company is also working on extending Green Technology Certification and has presented research at international academic conferences. Additionally, the company has signed a Research Cooperation MOU with the Korea Research Institute of Bioscience and Biotechnology (KRIBB) and has acquired Low Glycemic Food Certification for general foods in China. The launch of 2 data-submitted drugs and 4 generics, as well as the development of 33 in-house and 223 ODM new products. In FY2025, the company spent KRW75,402 million on R&D, which as a percentage of revenue, stood at 1.1%.